Andrew D Rendoff, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12315 N Vistoso Park Rd, Oro Valley, AZ 85755 Phone: 520-544-9700 Fax: 520-618-6060 |
Eric Alic Stricklin, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7725 N Oracle Rd, 131, Oro Valley, AZ 85704 Phone: 520-544-2273 Fax: 520-544-4227 |
Brianna Gruenwald, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 10370 N La Canada Dr Ste 150, Oro Valley, AZ 85737 Phone: 520-544-4100 |
Justin Michael Williams, PA-C Physician Assistant - Surgical Medicare: Accepting Medicare Assignments Practice Location: 257 E Crooked Stick Dr, Oro Valley, AZ 85737 Phone: 520-401-9171 |
Christopher Prescott, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 11232 N Quail Springs Pl, Oro Valley, AZ 85737 Phone: 520-247-5156 |
Amanda Catherine Berg, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 10370 N La Canada Dr Ste 150, Oro Valley, AZ 85737 Phone: 520-544-4100 |
Blaine Wesley Price, CSFA Physician Assistant - Surgical Medicare: Not Enrolled in Medicare Practice Location: 1551 E. Tangerine Rd Oro Valley Hospital, Oro Valley, AZ 85755 Phone: 520-901-3500 |
Sean Patrick Flynn, CSFA Physician Assistant - Surgical Medicare: Not Enrolled in Medicare Practice Location: 11248 N Platte Dr, Oro Valley, AZ 85737 Phone: 520-991-4071 |
Alyssa Mari Rehrer, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1521 E Tangerine Rd Ste 337, Oro Valley, AZ 85755 Phone: 520-901-6380 Fax: 520-901-6381 |
News Archive
An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans - by literally starving the parasites to death. The novel research, carried out on a small number of non-human primates, could bolster efforts to develop more potent therapies against one of the world's leading killers.
A selection of health policy stories from Minnesota, Texas, Louisiana, Florida, New York and Massachusetts.
A team of investigators at Rational Therapeutics, Inc. and the Malcolm Todd Cancer Institute (Long Beach, Calif.) has reported that functional profiling using ex-vivo analysis of programmed cell death (EVA/PCD) can be used to prescribe treatment regimens that double the response rate and survival in patients with Stage IV non-small cell lung cancer (NSCLC). The findings of their phase II clinical trial will be presented on Sunday, June 6th at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.
Researchers at Henry Ford Hospital in Detroit have uncovered previously unidentified genes that may be responsible for keloid scarring, a discovery that could unlock the mystery of keloid development and provide insight for more effective treatment.
› Verified 4 days ago